Furthermore, CRISPR disruption of a neighbouring CTCF binding site at a TAD boundary in wild-type tumours leads to the upregulation ofPDGFRA, providing mutant cells with a growth advantage and enhancing proliferation. This evidence concerns the gene CTCF and neoplasm.